🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)

RecruitingNAAges 18 Years - anyAllYale University
NCT06541028 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: PWID in general population: * Be a PWID from the general population enrolling into ART services at one of the study's HIV clinics. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD). * Provide informed consent. * HIV clinicians prescribing ART 1. Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics. 2. Be willing to use the RS-ART protocol. 3. Be at least 18 years old. No minors below age 18 will be enrolled in the study. 4. Provide informed consent. PWID in prison population: * Be a PWID enrolling into ART services at Kajang prison. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD). * Provide informed consent. Exclusion Criteria: \-
💊

What it tests

  • Rapid-Start ART (RS-ART)
📍

Where

3 sites
Kajang Prison
Kajang, Malaysia
Centre of Excellence for Research in AIDS (CERiA) - University of Malaya
Kuala Lumpur, Malaysia
Primary Healthcare Centers
Kuala Lumpur, Malaysia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy